Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS

被引：0
|
作者：
Baigel, Rachel [1 ]
Gregory, Ian [1 ]
机构：
[1] North Middlesex Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2024年 / 54卷 / 09期
关键词：
D O I：
10.1111/cea.14554
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：647 / 650
页数：4
相关论文
共 50 条
  • [31] EFFECT OF HIGH DOSE INHALED CORTICOSTEROID (ICS) MONOTHERAPY AND LOW-MODERATE DOSE ICS IN COMBINATION WITH LONG-ACTING β2-AGONISTS (LABA) THERAPY AMONG PATIENTS WITH UNCONTROLLED ASTHMA
    Xu, Z.
    Baojuan, L.
    Wei, L.
    Qiaoli, C.
    Kefang, L.
    RESPIROLOGY, 2013, 18 : 21 - 21
  • [32] Management of Chronic Obstructive Pulmonary Disease: Insights into Patient Profile - Use of Inhaled Corticosteroids/Long-Acting β2-Agonists or Long-Acting β2-Agonists/Long-acting Muscarinic Antagonists
    Kishore, Nevin
    Moitra, Saibal
    Sircar, Mrinal
    INDIAN JOURNAL OF RESPIRATORY CARE, 2020, 9 (02) : 162 - 170
  • [33] Once-daily long-acting beta 2-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
    Sliwka, Agnieszka
    Jankowski, Milosz
    Gross-Sondej, Iwona
    Storman, Monika
    Nowobilski, Roman
    Bala, Malgorzata M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [34] Nocturnal Asthma Uncontrolled by Inhaled CorticosteroidsTheophylline or Long-Acting β2 Agonists?
    Teresa D. Holimon
    Carol C. Chafin
    Timothy H. Self
    Drugs, 2001, 61 : 391 - 418
  • [35] Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
    Ducharme, Francine M.
    Lasserson, Toby J.
    Cates, Christopher J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (05):
  • [36] Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting 132 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting 132 Agonists Plus Inhaled Corticosteroids
    Liao, Pei-An
    Pan, Sheng-Wei
    Chen, Chun-Yu
    Deng, Chung-Yeh
    Dong, Yaa-Hui
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 553 - 563
  • [37] Safety of Long-Acting beta Agonists (LABA) with or without Inhaled Corticosteroids in Asthma
    Sadatsafavi, Mohsen
    Marra, Carlo
    Lynd, Larry
    FitzGerald, Mark
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 19 - 19
  • [38] High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: An observational study
    Thomas, Mike
    von Ziegenweidt, Julie
    Lee, Amanda J.
    Price, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 116 - 121
  • [39] High-Dose Inhaled Corticosteroid Versus Long-Acting β-Agonist Addition in Asthma
    Thomas, Mike
    Prince, David
    CHEST, 2009, 135 (05) : 1404 - 1405
  • [40] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247
12345